These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16046113)

  • 1. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.
    Viegi G; Pistelli R; Cazzola M; Falcone F; Cerveri I; Rossi A; Ugo Di Maria G
    Respir Med; 2006 Jan; 100(1):46-55. PubMed ID: 16046113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
    Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ
    Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment of community acquired pneumonia varies widely across Germany.
    Kohlhammer Y; Raspe H; Marre R; Suttorp N; Welte T; Schäfer T;
    J Infect; 2007 May; 54(5):446-53. PubMed ID: 17007933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pneumonia in ambulatory care patients. Choice of antibiotics for therapy of community-acquired pneumonia].
    Buchenroth M; Lorenz J
    Fortschr Med; 1998 Apr; 116(11):22-8, 30. PubMed ID: 9609921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.
    Gutiérrez F; Masiá M; Mirete C; Soldán B; Rodríguez JC; Padilla S; Hernández I; Royo G; Martin-Hidalgo A
    J Infect; 2006 Sep; 53(3):166-74. PubMed ID: 16375972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One drug or two? Step-down therapy after i.v. antibiotics for community-acquired pneumonia.
    Harrington Z; Barnes DJ
    Intern Med J; 2007 Nov; 37(11):767-71. PubMed ID: 17908087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of hospitalised pneumonia in Lazio, Italy, 1997-1999.
    Giorgi Rossi P; Agabiti N; Faustini A; Ancona C; Tancioni V; Forastiere F; Perucci CA
    Int J Tuberc Lung Dis; 2004 May; 8(5):528-36. PubMed ID: 15137527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based incidence of severe pneumonia in children in Kiel, Germany.
    Weigl JA; Puppe W; Belke O; Neusüss J; Bagci F; Schmitt HJ
    Klin Padiatr; 2005; 217(4):211-9. PubMed ID: 16032546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter study of the variability and adequacy of antimicrobial therapy for community-acquired pneumonia in adults].
    Artero A; Eiros JM; Ochoa C; Inglada L; Guerra L; Armadans L; Vallano A; Vidal JB; Martínez A; Lázaro A; Cerdá T; Ruiz A
    Rev Esp Quimioter; 1999 Dec; 12(4):352-8. PubMed ID: 10855015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the management of community-acquired pneumonia in adults. Italian Society of Pneumology. Italian Society of Respiratory Medicine. Italian Society of Chemotherapy.
    Gialdroni Grassi G; Bianchi L
    Monaldi Arch Chest Dis; 1995 Jan; 50(1):21-7. PubMed ID: 7742821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia due to Leptospira spp.: results of an epidemiological and clinical study.
    Perani V; Farina C; Maggi L; Michetti G; Moioli F; Pizzocaro P; Pugliese C
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):766-70. PubMed ID: 9755932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of malnutrition on risk and outcome of community-acquired pneumonia.
    Loeb M; High K
    Respir Care Clin N Am; 2005 Mar; 11(1):99-108. PubMed ID: 15763225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of community-acquired pneumonia in older adults: a population-based study.
    Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Raga-Luria X; Gomez-Bertomeu F;
    Respir Med; 2009 Feb; 103(2):309-16. PubMed ID: 18804355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.